Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-07-17
2007-07-17
Nickol, Gary B. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C424S192100, C435S069700, C530S300000, C530S402000
Reexamination Certificate
active
10063586
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6025156 (2000-02-01), Gwynn et al.
patent: 6737522 (2004-05-01), Sundick et al.
patent: WO 97/38085 (1997-10-01), None
patent: WO 00/12708 (2000-03-01), None
patent: WO 01/16318 (2001-03-01), None
Konopka et al., Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients, Proc. Natl. Acad. Sci. USA, 83:4049-4952, Jun. 1986.
Haynes et al., Proteome analysis: Biologica assay or data archive, Electrophoresis, 19:1862-1871, 1998.
Hu et al., Analysis of genomic and proteomic data using advanced literature mining, J. Proteome Res., 2:405-412, Jun. 2003.
Genes VI, Benjamin Lewin, 1997, excert from chapter 29 (includes pp. 847-848).
Greenbaum, et al. Genome Biology, (2003), vol. 4, Issue 9, Article 117, pp. 117.1-117.8.
Anderson et al., Electrophoresis, vol. 18, pp. 533-537, 1997.
Kawamoto et al., Gene, 1996, vol. 174, pp. 151-158.
Lian et al., 2001, Blood 98:513-524.
Fessler et al., 2002, J. Biol. Chem. 277:31291-31302.
Alberts, et al. 1994.Molecular Biology of the Cell, 3rd Edition, pp. 403-404, 453, New York: Garland Publishing.
Alberts, et al. 2002.Molecular Biology of the Cell 4th Edition, pp. 302, 363-364, 379, 435. New York: Garland Publishing.
Grimaldi, et al. 1989. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.Blood, 73(8):2081-2085.
Gygi, et al. Mar. 1999. Correlation between Protein and mRNA Abundance in Yeast.Molecular and Cellular Biology, 1720-1730.
Hanna, et al. Aug. 1999. HER-2
eu breast cancer predictive testing.Pathology Associates Medical Laboratories.
Hyman et al. Nov. 2002. Impact of DNA Amplification of Gene Expression Patterns.Cancer Research, 62:6240-6245.
Lewin, B. 1994. Oncogenes: Gene Expression and Cancer, Chap. 39, pp. 1196-1201.Genes V.New York: Oxford University Press.
Lewin, B. 1997. Regulation of Transcription, Chap. 29, pp. 847-848,Genes VI.New York: Oxford University Press.
Meeker, et al. 1990. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia.Blood, 76(2):285-289.
Meric, et al. 2002. Translation initiation in cancer: A novel target for therapy.Molecular Cancer Therapeutics, 1:971-979.
Ørntoft, et al. 2002. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.Molecular&Cellular Proteomics, 1:37-45.
Pollack, et al. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.PNAS, 99(20):12963-12968.
Singleton, et al. 1992. Clinical and pathologic significance of the c-erbB-2 (HER-2
eu) oncogene.Pathol. Annu, 1(27):165-190.
Zhigang, et al. 2004. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer.World Journal of Surgical Oncology, 2:13.
Allman, et al. 1996. BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Chen, et al. 2002. Discordant Protein and mRNA Expression in Lung Adenocarcinomas.Molecular&Cellular Proteomics 1.4, 304-313.
Hanash, S. 2003, Making sense of microarray data to classify cancer.The Pharmacogenomics Journal, 3:308-311.
Hanash, S. Mar. 2005, Integrated global profiling of cancer.Nature Reviews, Applied Proteomics Collection, pp. 9-14.
Hancock, W. S. 2004. Do We Have Enough Biomarkers?Journal of Proteome Research, 3(4):685.
Jang A. Hill RP, Sept. 1997. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells.Clin. Exp. Metastasis 15(5): pp. 469-483.
Abe, et al. “An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic tissue.”Br J Cancer. Dec. 1, 2003;89(11):2104-9. (Abstract Only).
Anderson, et al. 1997. A comparison of selected mRNA and protein abundances in human liver.Electrophoresis, 18:533-537.
Ando, et al. “Selective apoptosis of natural killer-cell tumours by I-asparaginase.”Br. J. Haematol. Sep. 2005;130(6):860-8. (Abstract Only).
Aust, et al. “Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.”Thyroid. Oct. 1997;7(5):713-24. (Abstract Only).
Barnes, et al. “Expression of embryonic fibronectin isoform EIIIA parallels alpha-smooth muscle actin in maturing and diseased kidney.”J Histochem Cytochem. Jun. 1999;47(6):787-98. (Abstract Only).
Bea, et al. “BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.”Cancer Res.Mar. 15, 2001;61(6):2409-12. (Abstract Only).
Allman, et al. 1996, BCL-6 expression during B-cell activation.Blood, 87(12):5257-5268.
Blaschke, et al. “Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology.”J Immunol Methods. Dec. 1, 2000; 246(1-2):79-90. (Abstract Only).
Buckley, et al. “Butyrate-induced reversal of dexamethasome resistance in autonomous rat Nb2 lymphoma cells.” Apoptosis. 1997;2(6):518-28. (Abstract Only).
Caberlotto, et al. “Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression.”Neurosci Lett.Apr. 23, 1999;265(3):191-4. (Abstract Only).
Caberlotto, et al. “Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.”Eur J Neurosci.May 2003;17(9):1736-46. (Abstract Only).
Celis, et al. 2000. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.FEBS Letters, 480:2-16.
Choi, et al. “Characterization of cyclin D2 expression in human endometrium.” 166:J Soc Gynecol Investig.Jan.-Feb. 2002;9(1):41-6. (Abstract Only).
Couvelard, et al. “Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus.”Virchows Arch.Sep. 2004;445(3):279-84. Epub Aug. 10, 2004. (Abstract Only).
Crick, F. 1970. Central dogma of molecular biology.Nature, 227:561-563.
Dagenais, et al. “Downregulation of ENaC activity and expression by TNF-alpha in alveolar epithelial cells.”Am J Physiol Lung Cell Mol Physiol. Feb. 2004;286(2):L301-11. Epub Sep. 26, 2003. (Abstract Only).
de Boer, et al. “Involvement of the CCND1 gene in hairy cell leukemia.”Ann Oncol. Mar. 1996;7(3):251-6. (Abstract Only).
Debieve, et al. “Inhibin and activin production and subunit expression in human placental cells cultured in vitro.”Mol Hum Reprod. Aug. 2000;6(8):743-9. (Abstract Only).
Dong, et al. “Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected withP. aeruginosa.” Invest Ophthalmol Vis Sci. Dec. 2001;42(13):3223-7. (Abstract Only).
Duchrow, et al. “Assessment of proliferative activity in colorectal carcinomas by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).”Cancer Invest. 2001;19(6):588-96. (Abstract Only).
Dyer, et al. “Molecular characterisation of carbohydrate digestion and absorption in equine small intestine.”Equine Vet
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Basi Nirmal S.
Genentech Inc.
Knobbe Martens Olson & Bear LLP
Kresnak Mark T.
LandOfFree
Pro1357 polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pro1357 polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro1357 polypeptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822289